This webinar explores the latest strategies for advancing retinal therapy development, addressing challenges in treating diseases like macular degeneration. It emphasizes global-to-local operational excellence, meaningful quality of life (QOL) endpoints, and clinical trial advocacy to navigate the rapidly evolving landscape of retinal research.